Showing 121 - 140 results of 151,595 for search '(( 10 ((we decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( 10 mg decrease ))', query time: 1.03s Refine Results
  1. 121
  2. 122
  3. 123
  4. 124
  5. 125
  6. 126

    Rhinorrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
  7. 127

    Vomit-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
  8. 128

    Symptoms free-days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
  9. 129

    Diarrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
  10. 130

    Nausea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
  11. 131

    Cough-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
  12. 132

    Dyspnea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
  13. 133

    <i>Trans ε</i> viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model by Martial Caillaud (6383672)

    Published 2019
    “…Here, effects of this stilbenoid were evaluated in transgenic APPswePS1dE9 mice. We report that <i>trans ε</i>-viniferin could go through the blood brain barrier, reduces size and density of amyloid deposits and decreases reactivity of astrocytes and microglia, after a weekly intraperitoneal injection at 10 mg/kg from 3 to 6 months of age.…”
  14. 134
  15. 135
  16. 136
  17. 137
  18. 138
  19. 139
  20. 140